Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

The Yin and Yang of Invariant Natural Killer T Cells in Tumor Immunity-Suppression of Tumor Immunity in the Intestine.

Wang Y, Cardell SL.

Front Immunol. 2018 Jan 10;8:1945. doi: 10.3389/fimmu.2017.01945. eCollection 2017. Review.

2.

Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy.

Shissler SC, Lee MS, Webb TJ.

Front Immunol. 2017 Nov 1;8:1447. doi: 10.3389/fimmu.2017.01447. eCollection 2017. Review.

3.

NF-κB Protects NKT Cells from Tumor Necrosis Factor Receptor 1-induced Death.

Kumar A, Gordy LE, Bezbradica JS, Stanic AK, Hill TM, Boothby MR, Van Kaer L, Joyce S.

Sci Rep. 2017 Nov 15;7(1):15594. doi: 10.1038/s41598-017-15461-y.

4.

Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.

Keller CW, Freigang S, Lünemann JD.

Front Immunol. 2017 May 24;8:570. doi: 10.3389/fimmu.2017.00570. eCollection 2017. Review.

5.

B cells interactions in lipid immune responses: implications in atherosclerotic disease.

Echeverri Tirado LC, Yassin LM.

Lipids Health Dis. 2017 Feb 6;16(1):30. doi: 10.1186/s12944-016-0390-5. Review.

6.

Activation strategies for invariant natural killer T cells.

Kohlgruber AC, Donado CA, LaMarche NM, Brenner MB, Brennan PJ.

Immunogenetics. 2016 Aug;68(8):649-63. doi: 10.1007/s00251-016-0944-8. Epub 2016 Jul 25. Review.

7.

Adoptive T Cell Therapy Targeting CD1 and MR1.

Guo T, Chamoto K, Hirano N.

Front Immunol. 2015 May 20;6:247. doi: 10.3389/fimmu.2015.00247. eCollection 2015. Review.

8.

An integrative view of microbiome-host interactions in inflammatory bowel diseases.

Wlodarska M, Kostic AD, Xavier RJ.

Cell Host Microbe. 2015 May 13;17(5):577-91. doi: 10.1016/j.chom.2015.04.008. Review.

9.

Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.

Schneidawind D, Baker J, Pierini A, Buechele C, Luong RH, Meyer EH, Negrin RS.

Blood. 2015 May 28;125(22):3491-500. doi: 10.1182/blood-2014-11-612762. Epub 2015 Mar 20.

10.

Protective mucosal immunity mediated by epithelial CD1d and IL-10.

Olszak T, Neves JF, Dowds CM, Baker K, Glickman J, Davidson NO, Lin CS, Jobin C, Brand S, Sotlar K, Wada K, Katayama K, Nakajima A, Mizuguchi H, Kawasaki K, Nagata K, Müller W, Snapper SB, Schreiber S, Kaser A, Zeissig S, Blumberg RS.

Nature. 2014 May 22;509(7501):497-502. doi: 10.1038/nature13150. Epub 2014 Apr 6.

11.

Lipid antigens in immunity.

Dowds CM, Kornell SC, Blumberg RS, Zeissig S.

Biol Chem. 2014 Jan;395(1):61-81. doi: 10.1515/hsz-2013-0220. Review.

12.

UVB-induced skin inflammation and cutaneous tissue injury is dependent on the MHC class I-like protein, CD1d.

Ryser S, Schuppli M, Gauthier B, Hernandez DR, Roye O, Hohl D, German B, Holzwarth JA, Moodycliffe AM.

J Invest Dermatol. 2014 Jan;134(1):192-202. doi: 10.1038/jid.2013.300. Epub 2013 Jul 18.

13.

Technical advance. Measurement of iNKT cell responses at the single-cell level against rare HIV-1-infected dendritic cells in a mixed culture.

Andersson SK, Paquin-Proulx D, Kroll M, Sandberg JK, Moll M.

J Leukoc Biol. 2013 Mar;93(3):449-55. doi: 10.1189/jlb.1012489. Epub 2012 Dec 21.

14.

Isolation and characterization of human primary enterocytes from small intestine using a novel method.

Chougule P, Herlenius G, Hernandez NM, Patil PB, Xu B, Sumitran-Holgersson S.

Scand J Gastroenterol. 2012 Nov;47(11):1334-43. doi: 10.3109/00365521.2012.708940. Epub 2012 Sep 4. Erratum in: Scand J Gastroenterol. 2016 Oct;51(10 ):1277-8.

15.

Alternative spliced CD1d transcripts in human bronchial epithelial cells.

Benam KH, Kok WL, McMichael AJ, Ho LP.

PLoS One. 2011;6(8):e22726. doi: 10.1371/journal.pone.0022726. Epub 2011 Aug 11.

16.

Lessons from type I interferons in ulcerative colitis.

Kaser A, Blumberg RS.

Gut. 2011 Apr;60(4):430-1. doi: 10.1136/gut.2010.229138. Epub 2011 Jan 25. No abstract available.

17.

CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV.

Miura S, Kawana K, Schust DJ, Fujii T, Yokoyama T, Iwasawa Y, Nagamatsu T, Adachi K, Tomio A, Tomio K, Kojima S, Yasugi T, Kozuma S, Taketani Y.

J Virol. 2010 Nov;84(22):11614-23. doi: 10.1128/JVI.01053-10. Epub 2010 Sep 1.

18.

Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.

Moll M, Andersson SK, Smed-Sörensen A, Sandberg JK.

Blood. 2010 Sep 16;116(11):1876-84. doi: 10.1182/blood-2009-09-243667. Epub 2010 Jun 8.

19.

A central role for transcription factor C/EBP-beta in regulating CD1d gene expression in human keratinocytes.

Sikder H, Zhao Y, Balato A, Chapoval A, Fishelevich R, Gade P, Singh IS, Kalvakolanu DV, Johnson PF, Gaspari AA.

J Immunol. 2009 Aug 1;183(3):1657-66. doi: 10.4049/jimmunol.0900057. Epub 2009 Jul 10. Erratum in: J Immunol. 2009 Sep 15;183(6):4135.

20.

Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.

Kim S, Lalani S, Parekh VV, Wu L, Van Kaer L.

Expert Rev Vaccines. 2008 Dec;7(10):1519-32. doi: 10.1586/14760584.7.10.1519. Review.

Supplemental Content

Support Center